De Novo Cell
De Novo Cell™ is a spinout from the University of Malta registered in Europe. The company is researching a proprietary procedure for the rapid and efficient production of induced pluripotent stem cells (iPSCs) from cord blood mononuclear cells and peripheral blood cells. Conversion rates between 80-90% are obtained in less than a month. The method uses small-molecule inducers and does not require feeder layer support, and the iPSCs produced are free of any genetic modification. De Novo Cell aims to carry out research and advance stem cell technology, with the aim of producing stem cells which are easily available in hospitals to treat multiple diseases.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
7
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at De Novo Cell
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at De Novo Cell
1 distinct titles indexed · top 1 shown.
- 1research scientist
Sign up to unlock all 1 contacts at De Novo Cell
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at De Novo Cell
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.